NEW YORK (GenomeWeb) – Women's health company Celmatix has received $4.5 million from the Empire State Development's New York City Regional Economic Development Council (REDC) to expand its headquarters in Manhattan, the company said today.
The award is one of 121 for projects in New York City this year, totaling $64.8 million. Overall, the REDC program awarded more than $755 million in funding to different regions of New York state in 2017.
Celmatix, founded in 2009, currently offers two products: Polaris, a web-based data analytics platform for patient management and counseling, and Fertilome, a genetic test to assess the risk for certain reproductive conditions.
Last month, the company received approval from the New York State Department of Health for the Fertilome test.